These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19304468)

  • 21. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
    Fernandes NF; Rosenbach M; Elenitsas R; Kist JM
    Arch Dermatol; 2009 Mar; 145(3):340-1. PubMed ID: 19289781
    [No Abstract]   [Full Text] [Related]  

  • 22. Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase.
    Saif MW; Black G; Johnson M; Russo S; Diasio R
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):771-5. PubMed ID: 16552574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential role of chemo-radiation with oral capecitabine in a breast cancer patient with central nervous system relapse.
    Hikino H; Yamada T; Johbara K; Obayashi N; Ozaki N
    Breast; 2006 Feb; 15(1):97-9. PubMed ID: 16005228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The prevention of diarrhea while under capecitabine therapy].
    Grouls V
    Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1750. PubMed ID: 18696410
    [No Abstract]   [Full Text] [Related]  

  • 25. [A case of cutaneous mammary re-irradiation].
    Jacob J; Pierga JY; Fourchotte V; Kirova YM; Bollet MA
    Cancer Radiother; 2012 Oct; 16(7):638-40. PubMed ID: 23092807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Onycholysis associated with capecitabine in patients with breast cancer.
    Hogeling M; Howard J; Kanigsberg N; Finkelstein H
    J Cutan Med Surg; 2008; 12(2):93-5. PubMed ID: 18346407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine.
    Villalón G; Martín JM; Pinazo MI; Calduch L; Alonso V; Jordá E
    Am J Clin Dermatol; 2009; 10(4):261-3. PubMed ID: 19489659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capecitabine induced inflammation of actinic keratoses.
    Krathen M; Treat J; James WD
    Dermatol Online J; 2007 Oct; 13(4):13. PubMed ID: 18319010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment.
    Peramiquel L; Dalmau J; Puig L; Roé E; Fernández-Figueras MT; Alomar A
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S119-20. PubMed ID: 17052530
    [No Abstract]   [Full Text] [Related]  

  • 30. Lichenoid photosensitive eruption due to capecitabine chemotherapy for metastatic breast cancer.
    Hague JS; Ilchyshyn A
    Clin Exp Dermatol; 2007 Jan; 32(1):102-3. PubMed ID: 16879449
    [No Abstract]   [Full Text] [Related]  

  • 31. Capecitabine induced colitis.
    Maggo G; Grover SC; Grin A
    Pathol Res Pract; 2014 Sep; 210(9):606-8. PubMed ID: 24947412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient.
    Aksoy S; Karaca B; Dinçer M; Yalçin S
    Ann Pharmacother; 2005 Mar; 39(3):573-4. PubMed ID: 15701780
    [No Abstract]   [Full Text] [Related]  

  • 33. Subacute cutaneous lupus erythematosus after treatment with capecitabine.
    Kindem S; Llombart B; Requena C; Ruiz A; Traves V; Guillen C; San Martin O
    J Dermatol; 2013 Jan; 40(1):75-6. PubMed ID: 22937906
    [No Abstract]   [Full Text] [Related]  

  • 34. Capecitabine-related cardiotoxicity: recognition and management.
    Saif MW; Tomita M; Ledbetter L; Diasio RB
    J Support Oncol; 2008 Jan; 6(1):41-8. PubMed ID: 18257400
    [No Abstract]   [Full Text] [Related]  

  • 35. [Myocardial ischaemia as a result of treatment with capecitabine].
    van Halteren HK; Liem AH; Planting AS
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1469-73. PubMed ID: 17633978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Capecitabine cardiac toxicity presenting as effort angina: a case report.
    Lestuzzi C; Crivellari D; Rigo F; Viel E; Meneguzzo N
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):700-3. PubMed ID: 20093950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute coronary syndrome induced by capecitabine therapy.
    Wijesinghe N; Thompson PI; McAlister H
    Heart Lung Circ; 2006 Oct; 15(5):337-9. PubMed ID: 16697705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reticulate Hyperpigmentation secondary to 5-fluorouracil and idarubicin.
    Jogi R; Garman M; Pielop J; Orengo I; Hsu S
    J Drugs Dermatol; 2005; 4(5):652-6. PubMed ID: 16167426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical picture: leopard-like vitiligo with capecitabine.
    Schmid-Wendtner MH; Wendtner CM; Volkenandt M; Heinemann V
    Lancet; 2001 Nov; 358(9293):1575. PubMed ID: 11716883
    [No Abstract]   [Full Text] [Related]  

  • 40. Antineoplastic agent-associated serpentine supravenous hyperpigmentation: superficial venous system hyperpigmentation following intravenous chemotherapy.
    Geddes ER; Cohen PR
    South Med J; 2010 Mar; 103(3):231-5. PubMed ID: 20134385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.